Skip to main content

JCVI to Use Pressure Bio's Sample Prep Technology in Microbiome Study

NEW YORK (GenomeWeb News) – Pressure BioSciences today said that it has entered into a collaboration with the J. Craig Venter Institute, under which JVCI has purchased one of the firm’s Barocycler NEP2320 PCT Sample Preparation Systems.
 
JVCI will use the system, which incorporates the firm’s pressure cycling technology, for its research as part of the NIH-funded Human Microbiome Project. Pressure Bio also intends to provide JCVI with two more instruments for additional studies as part of the collaboration.
 
In addition to using the instruments, JCVI will further develop the pressure cycling technology into its extraction protocols.
 
The technology is used for extracting nucleic acids and proteins from samples, and Scott Peterson, director of functional genomics research and technology at JCVI, said that it has “the unique ability to extract higher molecular weight DNA for further sequence analysis of the organisms we work with here at JCVI.”
 
South Easton, Mass.-based Pressure Bio also said that it has sold two PCT Sample Preparation Systems to an unnamed global pharmaceutical company.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.